Return to homepagePandemic Pact

Microbial comorbidities as factors of prognosis of COVID-19

Grant number: APQ-00267-20

Grant search

Key facts

  • Disease

    COVID-19

  • start year

    -99

  • Known Financial Commitments (USD)

    $18,104.78

  • Funder

    FAPEMIG Brazil

  • Principal Investigator

    Daniel De Assis Santos

  • Research Location

    Brazil

  • Lead Research Institution

    Universidade Federal de Minas Gerais

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Prognostic factors for disease severity

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

The Th2 Response and Alternative Activation of Macrophages Triggered by Strongyloides venezuelensis Is Linked to Increased Morbidity and Mortality Due to Cryptococcosis in Mice.

The impact of COVID-19 on antimicrobial prescription and drug resistance in fungi and bacteria.